首页> 外文期刊>Neuropharmacology >Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.
【24h】

Dopamine-opioid interactions in the rat striatum: a modulatory role for dopamine D1 receptors in delta opioid receptor-mediated signal transduction.

机译:大鼠纹状体中的多巴胺-阿片类药物相互作用:多巴胺D1受体在δ阿片类药物受体介导的信号转导中的调节作用。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Dopaminergic and opioidergic systems interact in the striatum to modulate locomotor and motivated behaviors. The present study investigated the molecular interactions of these two systems by determining the role of dopamine D1 and D2 receptors in the modulation of opioid receptor-mediated signal transduction. Male Fischer rats were injected daily for 10 days with either saline, the D1 receptor agonist SKF 82958, the D2 receptor agonist quinpirole, or both SKF 82958 and quinpirole. Administration of SKF 82958 alone or together with quinpirole attenuated the ability of the delta receptor agonist D-Pen2,D-Pen5-enkephalin (DPDPE) to inhibit adenylyl cyclase activity in the caudate putamen and nucleus accumbens. Quinpirole administration alone had no effect. The efficacy and potency of the mu opioid receptor agonist D-Ala2,N-Me-Phe4,Gly-ol5-enkephalin (DAMGO) to inhibit adenylyl cyclase activity was unaltered following administration of either dopamine receptor agonist. Administration of SKF 82958 had no affect on delta receptor binding, forskolin-stimulated adenylyl cyclase activity, or G protein/adenylyl cyclase coupling. However, the ability of DPDPE to stimulate binding of [35S]GTPgammaS to inhibitory G proteins was attenuated in animals that received SKF 82958. These results suggest that repeated activation of D1 receptors attenuates the functional coupling of delta opioid receptors with adenylyl cyclase due to decreased coupling between delta receptors and G proteins.
机译:多巴胺能和卵磷脂系统在纹状体中相互作用以调节运动和动机行为。本研究通过确定多巴胺D1和D2受体在阿片受体介导的信号传导调节中的作用,研究了这两个系统的分子相互作用。每天向雄性Fischer大鼠注射10天的生理盐水,D1受体激动剂SKF 82958,D2受体激动剂喹吡罗或SKF 82958和喹吡罗。单独或与喹吡罗一起施用时,SKF 82958的给药减弱了δ受体激动剂D-Pen2,D-Pen5-脑啡肽(DPDPE)抑制尾状壳核和伏核中腺苷酸环化酶活性的能力。单独服用喹吡罗无效。服用任何一种多巴胺受体激动剂后,μ阿片受体激动剂D-Ala2,N-Me-Phe4,Gly-ol5-脑啡肽(DAMGO)抑制腺苷酸环化酶活性的功效和效力均未改变。施用SKF 82958对δ受体结合,福司可林刺激的腺苷酸环化酶活性或G蛋白/腺苷酸环化酶偶联没有影响。然而,在接受SKF 82958的动物中,DPDPE刺激[35S] GTPgammaS与抑制性G蛋白结合的能力减弱。这些结果表明,D1受体的重复激活会降低δ阿片受体与腺苷酸环化酶的功能偶联,原因是其降低了δ受体和G蛋白之间的偶联。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号